PharmD Info

A forum for Indian Pharmacy Professionals

Indian PharmD PCI syllabus, Pharm D Notes Study Materials, PharmD Projects, Doctor of Pharmacy Colleges, Case Discussions, Question Papers.
  • User avatar
JHL Biotech's current capital value is $1.89 billion in New Taiwan dollars. The Taiwan Emerging Stock Board (ESB) is an introductory listing for companies before listing on Taipei Exchange (TPEx) or the Taiwan Stock Exchange (TWSE).

JHL Biotech's public offering is made by certain shareholders selling a portion of their current holdings of JHL Biotech's common stock. Yuanta Securities is the lead underwriter. Investors can contact JHL Biotech or buy directly from the Taiwan Emerging Stock Board.
Similar Topics
Topics Statistics Last post
0 Replies 
by Admin
06 Dec 2019, 16:51
0 Replies 
by Admin
28 Apr 2020, 17:04
Biotech Students-iGEM Award
by Prajith  - 01 Dec 2015, 09:59  - In: Pharma Magazine
1 Replies 
by Admin
01 Dec 2015, 17:13
0 Replies 
by Admin
12 Jul 2017, 22:30
0 Replies 
by Admin
19 Jan 2016, 16:23

A medical writer must be aware of different types […]

Thanks for the post

Benefits of Joint Replacement

Increased Mobility Pain relief Independence Les[…]

Good to know about these guidelines. But how we en[…]

E-Learn Portal